A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
for Colo-rectal Cancer
Drug: Cemiplimab
9 locations incl. Gainesville
Sponsor: NSABP Foundation Inc
Sex: All·Age: 18+
Code: NCT07058012·Phase 2·Recruiting